Gene therapy for ADA-SCID: defining the factors for successful outcome. (2012)

First Author: Gaspar HB
Attributed to:  Development of a lentiviral vector for gene therapy of ADA deficiency funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2012-08-446559

PubMed Identifier: 23118212

Publication URI: http://europepmc.org/abstract/MED/23118212

Type: Journal Article/Review

Volume: 120

Parent Publication: Blood

Issue: 18

ISSN: 0006-4971